Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antibiotic and antimicrobial agents > Daclatasvir
Daclatasvir
Inquiry
| Post Date: | Jan 17,2018 |
| Expiry Date: | Jul 16,2018 |
| Detailed Description: |
Cas No. :1009119-64-5
Quantity: 100Kilograms Hepatitis C |
| CAS Registry Number: | 1009119-64-5 |
| Synonyms: | ;Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, dimethyl ester;dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate;Methyl [(2S)-1-{(2S)-2-[5-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-imidazol-5-yl}-4-biphenylyl)-1H-imidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl]c arbamate;Daclatasvir; |
| Molecular Formula: | C40H50N8O6 |
| Molecular Weight: | 738.88 |
| Molecular Structure: | 
|
| Company: | Extranthis |
| Contact: | Dr. Thomas Kallimopoulos |
| Tel: | +496215454980 |
| Fax: | |
| Email: | t.kallimopoulos@extranthis.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
